Detalles de la búsqueda
1.
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes.
J Pharmacol Exp Ther
; 336(1): 165-77, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20947638
2.
The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.
J Pharmacol Exp Ther
; 327(3): 891-7, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18772320
3.
Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice.
Front Pharmacol
; 9: 208, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29599719
4.
Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociceptin receptors.
Pharmacol Res Perspect
; 4(6): e00275, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28097008
5.
LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy.
Front Neurosci
; 8: 5, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24478625
6.
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
J Pharmacol Exp Ther
; 315(3): 1265-77, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16141369
Resultados
1 -
6
de 6
1
Próxima >
>>